NCT03290560 - Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 19, 2018

Primary Completion Date

January 23, 2020

Study Completion Date

January 23, 2020

Conditions

Acute Ischemic Stroke

Interventions

DRUG

Recombinant human tissue kallikrein

OTHER

Placebo

Placebo Comparator: Phosphate buffered saline

Trial Locations (12)

Alfred Health, Melbourne

Royal Melbourne Hospital, Parkville

Lismore Base Hospital, Lismore

Liverpool Hospital, Liverpool

John Hunter Hospital, New Lambton Heights

Royal Brisbane and Women's Hospital, Herston

Princess Alexandria Hospital, Woolloongabba

Sunshine Hospital, St Albans

Fiona Stanley Hospital, Murdoch

Royal Adelaide Hospital, Adelaide

Ballarat Health Services, Ballarat

Box Hill Hospital, Box Hill